SCHEMBL9309021

SCHEMBL9309021

O=Cc1c(O)c2ccccc2c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 1/20 1.00
ERN1 O75460 6/20 0.52
HSP90AA1 P07900 1/20 0.45
S100A4 P26447 1/20 0.42
ALB P02768 1/20 0.40
TRIM24 O15164 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
THRB P10828 2/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12426364 0.90 PADI4 (0.82) PADI4ERN1HSP90AA1S100A4TRIM24
SCHEMBL28914736 0.90 PADI4 (0.82) PADI4ERN1HSP90AA1ALBTRIM24
SCHEMBL8576477 0.88 PADI4 (0.79) PADI4ERN1HSP90AA1S100A4ALB
SCHEMBL11627970 0.88 PADI4 (0.78) PADI4ERN1HSP90AA1S100A4TRIM24
SCHEMBL9511557 0.82 PADI4 (0.68) PADI4ERN1KDM4EMEN1ALDH1A1
SCHEMBL13044483 0.80 PADI4 (0.67) PADI4ERN1HSP90AA1TRIM24TRIM33
SCHEMBL986883 0.79 PADI4 (0.64) PADI4ERN1KDM4EMEN1ALDH1A1
SCHEMBL29588097 0.79 PADI4 (0.64) PADI4ERN1KDM4EMEN1ALDH1A1
SCHEMBL3268833 0.79 PADI4 (0.64) PADI4ERN1ALBKDM4EMEN1
SCHEMBL28714558 0.78 PADI4 (0.63) PADI4ERN1ALBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230103089-A1 RESIST UNDERLAYER COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION SAMSUNG SDI CO., LTD. (KR) 2023-03-30 US disclosed
CN-115685674-A Resist underlayer composition and method for forming pattern using the same 三星SDI株式会社 2023-02-03 CN disclosed
EP-3653574-B1 SURFACE-MODIFIED INORGANIC NITRIDE, COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, DEVICE PROVIDED WITH THERMALLY CONDUCTIVE LAYER FUJIFILM CORP (JP) 2021-01-06 EP disclosed
EP-3653574-A1 SURFACE-MODIFIED INORGANIC NITRIDE, COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, DEVICE PROVIDED WITH THERMALLY CONDUCTIVE LAYER FUJIFILM Corporation (JP) 2020-05-20 EP disclosed
US-20200140275-A1 SURFACE-MODIFIED INORGANIC NITRIDE, COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, AND DEVICE WITH THERMALLY CONDUCTIVE LAYER FUJIFILM CORPORATION (JP) 2020-05-07 US disclosed
US-20090124787-A1 Method for Producing Polyhydroxyalkanoates BASF AKTIENGESELLSCHAFT (DE) 2009-05-14 US disclosed
US-20090124787-A1 Method for Producing Polyhydroxyalkanoates BASF AKTIENGESELLSCHAFT (DE) 2009-05-14 US disclosed
EP-1874845-B1 METHOD FOR PRODUCING POLYHYDROXYALKANOATES BASF SE (DE) 2008-08-27 EP disclosed
US-5294522-A Photochromic compound CHISSO CORPORATION (JP) 1994-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230103089-A1 RESIST UNDERLAYER COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION POP1, TOP1, RER1 PADI4 2163/4885ERN1 380/4885HSP90AA1 3142/4885
US-20090124787-A1 Method for Producing Polyhydroxyalkanoates LDHB, ACADM, HSD17B12 PADI4 825/4885ERN1 1195/4885HSP90AA1 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.